All News

MSK Ultrasound demonstrated continued improvement of synovitis and enthesitis in PsA pts on secukinumab. ⭐️continued improvement of GLOESS (synovitis) and OMERACT enthesitis score at 52 weeks Abs#1360 #ACR21 @RheumNow https://t.co/ISVZrXkEiI https://t.co/dXlfi3R962

Links:

Robert B Chao, MD doctorRBC ( View Tweet)
Routine evaluation of MRE and MRI in Crohn's Disease could be a way to detect axSpa. 25% of 48 CD patients had abnormal SI joint finding, majority asymptomatic, female, and had stricturing or penetrating CD @RheumNow #ACR21 Abst#1306 #ACRBest https://t.co/MYMV3UDGck https://t.co/p9fov02OdH

Links:

Dr. Antoni Chan synovialjoints ( View Tweet)
What matters for PsA pts & MDs? In this study, pts and MDs in consensus w/#arthritis dse activity, fatigue & pain as impt aspects of PsA care; but disparities still exist👇 MDs-clinical Pts-access to care, sleep Communication is🔑➡shared decision making @RheumNow #ACR21 abs1165 https://t.co/Zd4r47OMGx
sheila RHEUMarampa ( View Tweet)
A clever hack for those who have difficulty with public speaking! I would add breathe to this list! Janet Zeide presents "RHEUM" during The Gift of Gab at #ACR21 @RheumNow https://t.co/fjAFZDiao5
Dr. Rachel Tate uptoTate ( View Tweet)
A retrospective cohort study demonstrates a statistically and clinically significant lower risk for developing PsA among patients with psoriasis that receive biologic medications Abst #1355 #ACR21 @RheumNow https://t.co/OK20VKO82f
swethaann23 swethaann23 ( View Tweet)
@SattuiSEMD on frailty in PMR. High prevalence frailty (12-17%) and pre-frailty (54-59%). Frailty associated worse HRQoL. Abstr#1392 #ACR21 @RheumNow https://t.co/Y2evVHrrTa
Richard Conway RichardPAConway ( View Tweet)
#ACR21 Opening Day Recap: Drs. Cush, Dao ( @KDAO2011) , Tate ( @uptotate) and Reyes ( @RHEUMarampa ) https://t.co/v0DH4jY84v https://t.co/oflVOkzSie

Links:

Dr. John Cush RheumNow ( View Tweet)
"If you follow this advice👇, you will be the best speaker in the RHEUM!" 😉😊🤓 @RheumNow #ACR21 https://t.co/y2IYMFJChE
sheila RHEUMarampa ( View Tweet)
Efficacy to the COVID-19 vaccine is based on both humoral (antibody) and cellular responses. Rituximab impairs B-cell response but not T-cell response to COVID-19 vaccine in auto-immune diseases @RheumNow #ACR21 8M101 Mariette X https://t.co/RoFTC6VpCt
Dr. Antoni Chan synovialjoints ( View Tweet)
Prevalence of abnormal SI joint findings on MRE and MRI is 25% in Crohn's pts. Majority didn't report back pain, were female, and had intestinal complications of CD. Abs 1306 #ACR21 #RheumNow @RheumNow https://t.co/LOGoxAfrQi https://t.co/qAKC8GCLno

Links:

Dr. Rachel Tate uptoTate ( View Tweet)
Abst1005 #ACR21 #ACRBest @RheumNow study identifies monocyte-derived DC population characterized as CD209+/CD14+ DC in the synovium of RA and PsA patients sensitive to JAK/STAT, but not TNF inhibition.

Olga Petryna DrPetryna ( View Tweet)

VACOLUP study: COVID19 vacc, 1189 SLE pts 👉No sig. diff based on gender, age, nor type of vax 👉3.2% pts w/SLE flare 👉Flares mainly fatigue and MSK symptoms (SLE flare or side-effect of the vac?) https://t.co/w5dYsLkk5D #ACR21 Abst#1421 @RheumNow #ACRBest

Links:

Pedro Castillo _Castillo_Pedro ( View Tweet)

Dr Keen presenting on GCA admitted to hospital. Propensity score matched to non-GCA population. Increased all cause mortality compared to general population in Western Australia (aHR 1.13). Most pronounced in early years after diagnosis. Abstr#1393 #ACR21 @RheumNow https://t.co/laW8mxp6uq
Richard Conway RichardPAConway ( View Tweet)
Dr Björn Bühring highlights the burden of #multimorbidity and particularly #sarcopenia in older patients with #rheumatoidarthritis. #ACR21 @RheumNow https://t.co/3xGtx48DAU
Mrinalini Dey DrMiniDey ( View Tweet)
Majority of rheum pts on csDMARDs, TNFi, JAKi & TCZ had adequate serologic response to m-RNA based vaccines. Poor vaccine reactivity mainly assoc'd w/ RTX, steroids, and MMF. Study did not include ABA. Abs 1087 #ACR21 #RheumNow #ACRbest @RheumNow https://t.co/q4C66Htz5a https://t.co/MS7cqdFWBi

Links:

Dr. Rachel Tate uptoTate ( View Tweet)
Abst1083 #acr21 #ACRBest @RheumNow study of COVID-19 outcomes in pts w/systemic auto inflammatory disease:31% had a flare of underlying SAID, either concurrently (20%) or after recovering from COVID-19 (11%). The majority of SAID pts w/COVID-19 reported mild to moderate illness https://t.co/qzYfmYpA25
Olga Petryna DrPetryna ( View Tweet)
Important to properly assess #sarcopenia in older patients with #RA. Useful tools include: 👉🏼SARC-F questionnaire (≥ 4 is abnormal) 👉🏼Muscle function tests incl Short Physical Performance Battery #ACR21 @RheumNow https://t.co/9l6b7tJ1xC
Mrinalini Dey DrMiniDey ( View Tweet)
Retrospective French case study showed PAH is rare but potentially severe complication of AOSD. In this trial of 13, it only affected women. Further studies needed! Abs 1100 #ACR21 #RheumNow @RheumNow https://t.co/6CufqRV0Qg https://t.co/h73mxsJswi

Links:

Dr. Rachel Tate uptoTate ( View Tweet)
Abst1094 #acr21 @RheumNow rheum pts and extremely ⬆️ESR: infection vs flare: Thrombocyte, MCV, albumin and total protein were significantly lower in infection group, however; neutrophil, MPV, CRP and ferritin were significantly lower in flare-up group https://t.co/C6MQo86Ljb
Olga Petryna DrPetryna ( View Tweet)
Urinary CD163: Potential Biomarker in LN 💠Correlated w/histological activity 💠⬆️in prolif LN 💠⬇️in responders 💠Clinical features + biomarkers may provide non-invasive method to dx and monitor response in LN https://t.co/u910ehQH74 #ACR2021 Abst#1422 @RheumNow #ACRBest

Links:

Pedro Castillo _Castillo_Pedro ( View Tweet)

×